Your browser doesn't support javascript.
loading
Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.
Zhang, Bo; Cheng, Zhifeng; Chen, Ji; Zhang, Xin; Liu, Dexue; Jiang, Hongwei; Ma, Guoqing; Wang, Xiaoyun; Gan, Shenglian; Sun, Juan; Jin, Ping; Yi, Jianjun; Shi, Bimin; Ma, Jianhua; Ye, Shandong; Wang, Guixia; Ji, Linong; Gu, Xuejiang; Yu, Ting; An, Pei; Deng, Huan; Li, Haoyu; Li, Li; Ma, Qingyang; Qian, Lei; Yang, Wenying.
Afiliación
  • Zhang B; Department of Endocrinology, China-Japan Friendship Hospital, Beijing.
  • Cheng Z; Department of Endocrinology and Metabolism, Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Chen J; Innovent Biologics, Inc., Suzhou, China.
  • Zhang X; Department of Endocrinology and Metabolism, Genertec Liaoyou Gem Flower Hospital, Panjin, China.
  • Liu D; Department of Endocrinology, First Affiliated Hospital of Nanyang Medical College, Nanyang, China.
  • Jiang H; Department of Endocrinology, First Affiliated Hospital and Clinical Medicine College, Henan University of Science and Technology, Luoyang, China.
  • Ma G; Department of Endocrinology and Metabolism, Second Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, Harbin, China.
  • Wang X; Department of Endocrinology, Cangzhou Hospital of Integrated TCM-WM, Cangzhou, China.
  • Gan S; Department of Endocrinology, First People's Hospital of Changde City, Changde, China.
  • Sun J; Department of Endocrinology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Jin P; Department of Endocrinology, Third Xiangya Hospital of Central South University, Changsha, China.
  • Yi J; Department of Endocrinology, First People's Hospital of Xiangtan City, Xiangtan, China.
  • Shi B; Department of Endocrinology, First Affiliated Hospital of Soochow University, Suzhou, China.
  • Ma J; Department of Endocrinology, Nanjing First Hospital, Nanjing, China.
  • Ye S; Department of Endocrinology, Anhui Provincial Hospital, Hefei, China.
  • Wang G; Department of Endocrinology and Metabolism, First Hospital of Jilin University, Changchun, China.
  • Ji L; Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China.
  • Gu X; Department of Endocrinology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Yu T; Innovent Biologics, Inc., Suzhou, China.
  • An P; Innovent Biologics, Inc., Suzhou, China.
  • Deng H; Innovent Biologics, Inc., Suzhou, China.
  • Li H; Innovent Biologics, Inc., Suzhou, China.
  • Li L; Innovent Biologics, Inc., Suzhou, China.
  • Ma Q; Innovent Biologics, Inc., Suzhou, China.
  • Qian L; Innovent Biologics, Inc., Suzhou, China.
  • Yang W; Department of Endocrinology, China-Japan Friendship Hospital, Beijing.
Diabetes Care ; 47(1): 160-168, 2024 Jan 01.
Article en En | MEDLINE | ID: mdl-37943529
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 Límite: Adult / Humans País/Región como asunto: Asia Idioma: En Revista: Diabetes Care Año: 2024 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 Límite: Adult / Humans País/Región como asunto: Asia Idioma: En Revista: Diabetes Care Año: 2024 Tipo del documento: Article